Clinical Utility of CDMT Among VillageMD Providers

NCT05658653 | Completed

• 1 other identifier: Pro00064387
• Study Type: interventional
• Target: 166
• Locations: 1 country
• Sites: 1

Brief Summary

This is a health system-level research study of physicians and care providers. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling, and other) of a subset of common patient care indications.

Conditions

Chronic Disease; Drug Drug Interaction; Medication Adherence

Outcome Measures

Primary Outcomes (3)

• Clinical Performance and Value (CPV) -measured variation in assessment

  Using the responses to the simulated patient cases to measure the baseline levels of variation in the work-up, recognition, and management of medication non-adherence and/or DDI in patients with more than one cardiometabolic condition and associated polypharmacy. Work-up, recognition, and management scores will be combined to report variation in total assessment of the simulated patient cases.

  [4 months]

• CPV-measured change in treatment Quality

  Measuring the difference in the quality of overall diagnostic scores between control participants using standard-of-care diagnostic tools and intervention participants using the CDMT. Scores will be on a scale of 0-100 with 100 representing the ideal management of a simulated patient.

  [4 months]

• CPV-measured difference in amount of evidence-based decisions

  Differences in number of evidence-based decisions, particularly prescribing decisions, made by intervention providers and control providers, while controlling for provider and practice characteristics, between rounds 1 and 2.

  [4 months]

Secondary Outcomes (1)

• CPV-measured differences in cost of care between control and intervention arms

  [4 months]

Study Arms (2)

Standard Practice

NO INTERVENTION

The Control group treats their simulated patients using standard practice and has no introduction to the new CDMT test.

Chronic Disease Management Test (CDMT)

EXPERIMENTAL

The intervention will receive information regarding the CDMT test and will be given the test results, whether selected or not, in Round 2 of CPV administration.

Other: Educational Materials for Chronic Disease Management Test (CDMT)

Interventions

Educational Materials for Chronic Disease Management Test (CDMT) OTHER

These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report.

Chronic Disease Management Test (CDMT)

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Licensed primary care provider (PCP) (MD, DO, NP, PA) currently practicing in the following areas: a) Internal medicine b) Family medicine
• Have practiced as a PCP in internal or family medicine for greater than 2 but less than 30 years
• practicing in a community / non-academic based practice setting
• ≥ 40 patients under care weekly
• Commonly treats patients with congestive heart failure/atrial fibrillation, diabetes, hypertension, and COPD
• Practicing in the United States
• English-speaking
• Access to the internet
• Informed and voluntarily consented to be in the study

You may not qualify if:

• Non-English speaking
• Not a licensed primary care provider
• Unable to access the internet
• Not practicing in the U.S.
• Do not voluntarily consent to be in the study

Sponsors & Collaborators

• Qure Healthcare, LLC: lead

Study Sites (1)

QURE Healthcare

San Francisco, California, 94109, United States

Location

MeSH Terms

Conditions

Chronic Disease; Medication Adherence

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Patient Compliance; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Model Details: The study will enroll physicians and care providers practicing in the VillageMD health system. Participants are randomly assigned to either control or intervention 1 arms upon enrollment. All eligible and consented participants will complete two rounds of three patient simulations. The intervention arm only will receive educational material about the CDMT test in between these two rounds. Intervention arm participants only will receive the CDMT test results whether they select it or not.

Study Record Dates

• First Submitted: December 2, 2022
• First Posted: December 21, 2022
• Study Start: August 16, 2022
• Primary Completion: January 10, 2023
• Study Completion: January 10, 2023
• Last Updated: March 29, 2023

Record last verified: 2023-03

Locations

US (1)